-
Cytodyn Inc
reported that the
primary endpoint had been
achieved in the PRO 140
pivotal combination therapy trial in HIV infection. In 2020
CytoDyn submitted...
-
atezolizumab in
combination with the
chemotherapy nab-pa****axel. In 2019,
CytoDyn initiated a
Phase 1b/2
trial with its
humanized monoclonal antibody, leronlimab...
- "
Cytodyn Initiates First Clinical Site for
Phase 3
Trial of PRO 140".
CytoDyn (Press release).
Retrieved 2015-08-22. [verification needed] "
CytoDyn Reports...
- In
January 2019,
Pestell was
named Vice
Chairman of the
Board of the
CytoDyn, Inc.,
which acquired his
prior company, ProstaGene, in
November 2018....
- and the HIV co-receptor CCR5.
These experimental drugs include PRO140 (
CytoDyn),
Vicriviroc (Phase III
trials were
cancelled in July 2010) (Schering Plough)...
-
countdown in the
first place. In
November 2020,
amfAR signed an
agreement with
CytoDyn Inc. to
explore the
potential of its CCR-5
antagonist Vyrologix (Leronlimab)...
-
Decades of
invention and discovery". Cytometry. 83A (5): 424–438. doi:10.1002/
cyto.a.22296. PMID 23596093. S2CID 37274992. Hagve, T-A (2007). "Fra mikroskop...
-
invention and discovery".
Cytometry Part A. 83A (5): 424–438. doi:10.1002/
cyto.a.22296. ISSN 1552-4922. PMID 23596093. Graham, MD (2013). "The
Coulter principle:...
